Celselect Slide TechnologyTM
A better way for enrichment and enumeration of circulating tumor cells
Circulating tumor cells (CTCs) offer several advantages or are complementary to other biomarkers in liquid biopsies. CTCs can be analyzed in their entirety, revealing key insights about targetable receptors and tumor heterogeneity and mutations. CTC concentration is also a corollary of disease progression and related to a patient’s response to therapy. The potential of CTCs had previously gone untapped because of the lack of technology to efficiently capture and characterize these cells.
Enumeration Workflow

The Advantages of Celselect Slide TechnologyTM
- Capture mechanism: works independently of surface markers and isolates cells regardless of phenotypic transitions, for example, the epithelial to mesenchymal transition (EMT).
- Multiple applications: perform on‑slide immunohistochemical analysis or return viable cells for any downstream analysis.
- Sample preparation: process whole blood and other liquid biopsies without manipulation (centrifuging or cell lysis).
- Customization: the system is antibody panel agnostic, and its open nature permits changing staining and incubation conditions.

Celsingle Slide TechnologyTM
Analyze Molecular Signatures from Hundreds to Tens of Thousands of Single Cells
CelsingleTM Slides offer researchers the ability to analyze molecular signatures from hundreds to tens of thousands of single cells, for a unique and comprehensive view of life science and clinical research. Utilizing microwell technology, CelsingleTM Slides support multi‑omic applications enabling characterization of both RNA and protein at single‑cell resolution.


Other Single‑Cell Solutions at Bio‑Rad
Featuring Bio‑Rad’s Droplet Digital technology, the SureCell ATAC‑Seq Library Prep Kit offers fast, sensitive and scalable profiling of the epigenomic landscape at the single‑cell level. For more, visit:
SureCell ATAC‑Seq Library Prep KitLife Science Research
Bio‑Rad
Be the first to know!
Sign up to be notified of new product launches and discoveries in single‑cell analysis.